Strategy

Why industry is investing in bispecific molecules

Read more

Europe's biotechs succeed without partners

Read more

Good deals getting harder for Pharma

Read more

Deciding the best cancer combinations

Read more

Report from Singapore: Creating incentives for life science innovation

Read more

Pharma has its sights on European academia

Read more

European biotechs post fourth annual advance

Read more

Pharma dealmaking has been smarter in 2015

Read more

Europe's new unitary patent

Read more

A US approach to value-based drug assessment

Read more